Colposcopic features of cervical oncotropic papilloma-virus infection in patients with various pathology of uterine cervix
- Authors: Kolomiyets L.A.1, Churuksayeva O.N.1, Urazova L.N.1, Sevostyanova N.V.1
-
Affiliations:
- Tomsk Scientific Center of the Siberian Branch of the Russian Academy of Medical Sciences, Research Institute of Oncology
- Issue: Vol 51, No 4 (2002)
- Pages: 48-51
- Section: Current public health problems
- URL: https://bakhtiniada.ru/jowd/article/view/91120
- DOI: https://doi.org/10.17816/JOWD91120
- ID: 91120
Cite item
Full Text
Abstract
In order to estimate the colposcopic manifestations of cervical oncotropic human papilloma-virus (HPV)-infection, a total of 693 patients were examimed. Among them, there were 298 patients with benign tumors pathology, 57 patients with 1-3 Grade cervical dysplasia of mucosa, 50 patients with uterine cervix cancer, 288 healthy women.
All patients underwent bimanual examination, taking of cervical smears for cytological examination and uterine cervix colposcopy. Diagnosis for HPV16/18 infection was made by the method of polimerase chain reaction.
А large variety in colposcopic manifestations of HPV-infection was found, namely: areas of atypical vessels, leukoplakia sites,fields of atypical epithelium, iodine-negative sites. It was related to the influence of oncogenic types of HPV infection. In these patients,fields of atypical epithelium, atypical vessels, iodinenegative areas were observed 1.2, 2.5, 10.5 times more frequently, respectively.
It was found that all varieties of papillomas occurred among patients with pathology, whereas flat condylomas presenting the most difficulties of or diagnosis prevailed in patients with cervical neoplasms and uterine cervix cancer The most pronounced colposcopic evidences of uterine cervix epithelium malignancy were observed in patients with virus-positive uterine cervix cancer.
Full Text
##article.viewOnOriginalSite##About the authors
L. A. Kolomiyets
Tomsk Scientific Center of the Siberian Branch of the Russian Academy of Medical Sciences, Research Institute of Oncology
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Tomsk
O. N. Churuksayeva
Tomsk Scientific Center of the Siberian Branch of the Russian Academy of Medical Sciences, Research Institute of Oncology
Email: info@eco-vector.com
Russian Federation, Tomsk
L. N. Urazova
Tomsk Scientific Center of the Siberian Branch of the Russian Academy of Medical Sciences, Research Institute of Oncology
Email: info@eco-vector.com
Russian Federation, Tomsk
N. V. Sevostyanova
Tomsk Scientific Center of the Siberian Branch of the Russian Academy of Medical Sciences, Research Institute of Oncology
Email: info@eco-vector.com
Russian Federation, Tomsk
References
Supplementary files
